Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Shares Shorted: Short Interest Down 56.5% in September

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a large decline in short interest in September. As of September 30th, there was short interest totaling 1,378,001 shares, a decline of 56.5% from the September 15th total of 3,166,158 shares. Based on an average daily trading volume, of 43,882 shares, the days-to-cover ratio is presently 31.4 days.

Kyowa Kirin Price Performance

KYKOF stock opened at $13.90 on Tuesday. The business’s 50-day simple moving average is $14.72 and its 200 day simple moving average is $14.40. Kyowa Kirin has a twelve month low of $4.20 and a twelve month high of $15.90.

Analysts Set New Price Targets

Separately, Jefferies Financial Group downgraded shares of Kyowa Kirin to a “hold” rating in a report on Tuesday, September 8th. One investment analyst has rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce”.

About Kyowa Kirin

Kyowa Kirin Co, Ltd. is a Japan-based specialty pharmaceutical company that researches, develops, manufactures and markets prescription medicines. The company focuses on therapies for areas including oncology, immunology, nephrology, the central nervous system and rare diseases, with an emphasis on biologics and other innovative treatments.

Its products include Poteligeo (mogamulizumab), an antibody used in certain hematologic cancers and cutaneous T-cell lymphomas, and Crysvita (burosumab), a treatment for disorders involving abnormal phosphate regulation.